REFERENCES
598.
Smith PL, Kagey-Sobotka A, Bleecker ER, et al:
Physiologic manifestations of human anaphylaxis. J Clin Invest 66:1072, 1980.
599.
Delage C, Irey NS: Anaphylactic deaths: A clinicopathologic
study of 43 cases. J Forensic Sci 17:525, 1972.
600.
Bettman MA: Radiographic contrast agents—a
perspective. N Engl J Med 317:891, 1987.
601.
Chenoweth DE, Cooper SW, Hugli TE, et al: Complement
activation during cardiopulmonary bypass. N Engl J Med 304:497, 1981.
602.
Craddock PR, Fehr J, Brigham KL, et al: Complement
and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296:769,
1977.
603.
Roizen MF, Rodgers GM, Valone FH, et al: Anaphylactoid
reactions to vascular graft material presenting with vasodilation and subsequent
disseminated intravascular coagulation. Anesthesiology 71:331, 1989.
604.
Swanson MC, Bubak ME, Hunt LW, et al: Quantification
of occupational latex aeroallergens in a medical center. J Allergy Clin Immunol
94:445, 1994.
605.
Mertes PM, Laxenaire MC: Allergic reactions occurring
during anaesthesia. Eur J Anaesthesiol 19:240–262, 2002.
606.
Lieberman P: Anaphylactic reactions during surgical
and medical procedures. J Allergy Clin Immunol 110(2 Suppl):S64–S69, 2002.
607.
Rosow CE, Moss J, Philbin DM, et al: Histamine
release during morphine and fentanyl anesthesia. Anesthesiology 56:93, 1982.
608.
Moss J, Rosow CE, Savarese JJ, et al: Role of
histamine in the hypotensive action of d-tubocurarine
in humans. Anesthesiology 55:19, 1981.
609.
Millbern SM, Bell SD: Prevention of anaphylaxis
to contrast media. Anesthesiology 50:56, 1979.
610.
Moss J, McDermott DJ, Thisted RA, et al: Anaphylactic/anaphylactoid
reactions in response to Chymodiactin (chymopapain). Anesth Analg 63:253, 1984.
611.
Philbin DM, Moss J, Akins CW, et al: The use
of H1
and H2
histamine antagonists with morphine anesthesia:
A double-blind study. Anesthesiology 55:292, 1981.
612.
Halevy S, Altura BT, Altura BM: Pathophysiological
basis for the use of steroids in the treatment of shock and trauma. Klin Wochenschr
60:1021, 1982.
613.
Ring J, Messmer K: Incidence and severity of
anaphylactoid reactions to colloid volume substitutes. Lancet 1:466, 1977.
614.
Milner LV, Butcher K: Transfusion reactions reported
after transfusion of red blood cells and of whole blood. Transfusion 18:493, 1978.
615.
Barach EM, Nowak RM, Lee TG, et al: Epinephrine
for treatment of anaphylactic shock. JAMA 251:2118, 1984.
616.
Toogood JH: Risk of anaphylaxis in patients receiving
beta-blocker drugs. J Allergy Clin Immunol 81:1, 1988.
617.
Van Arsdel PP Jr, Larson EB: Diagnostic tests
for patients with suspected allergic disease. Ann Intern Med 110:304, 1989.
618.
Del Pizzo A: Hereditary angioneurotic edema.
Anesthesiol Rev 5:41, 1978.
619.
Hosea SW, Santaella ML, Brown EJ, et al: Long-term
therapy of hereditary angioedema with danazol. Ann Intern Med 93:809, 1982.
620.
Oxelius V-A, Laurell A-B, Lindquist B, et al:
IgG subclasses in selective IgA deficiency. Importance of IgG2-IgA deficiency.
N Engl J Med 304:1476, 1981.
621.
Fauci AS, Rosenberg SA, Sherwin SA, et al: Immunomodulators
in clinical medicine. Ann Intern Med 106:421, 1987.
622.
Levy DE, Caronna JJ, Singer BH, et al: Predicting
outcome from hypoxic-ischemic coma. JAMA 253:1420, 1985.
623.
Plum F, Posner JB: The Diagnosis of Stupor and
Coma. 3rd ed. Philadelphia, FA Davis, 1980.
624.
Lowenstein DH, Massa SM, Rowbotham MC, et al:
Acute neurologic and psychiatric complications associated with cocaine abuse. Am
J Med 83:841, 1987.
625.
Barry PP, Moskowitz MA: The diagnosis of reversible
dementia in the elderly, a critical review. Arch Intern Med 148:1914, 1988.
626.
Boguosslavsky J, Meineberg O: Eye-movement disorders
in brain-stem and cerebellar stoke. Arch Neurol 44:141, 1987.
627.
Drugs for epilepsy. Med Lett Drugs Ther 45:57–64,
2003.
628.
Roberts R: Differential diagnosis of sleep disorders,
non-epileptic attacks and epileptic attacks. Curr Opin Neurol 11:135–9, 1998.
629.
Shaner DM, McCurdy SA, Herring MO, et al: Treatment
of status epilepticus: A prospective comparison of diazepam and phenytoin versus
phenobarbital and optional phenytoin. Neurology 38:202, 1988.
630.
Joas TA, Stevens WC, Eger EI II: Electroencephalographic
seizure activity in dogs during anesthesia. Br J Anaesth 43:739, 1971.
631.
Opitz A, Brechts B, Stenzel E: Enflurane anaesthesia
for epileptic patients. Anaesthesist 26:329, 1977.
632.
Schuchat A, Robinson K, Wenger JD, et al: Bacterial
meningitis in the United States in 1995. N Engl J Med 337:970, 1997.
633.
Parkinson Study Group: Impact of deprenyl and
tocopherol treatment on Parkinson's disease in DATA TOP patients requiring levodopa.
Ann Neurol 39:37, 1996.
634.
Goetz CG, Olanow CW, Koller WC, et al: Multicenter
study of autologous adrenal medullary transplantation to the corpus striatum in patients
with advanced Parkinson's disease. N Engl J Med 320:337, 1989.
635.
Mets B: Acute dystonia after alfentanil in untreated
Parkinson's disease. Anesth Analg 72:557, 1991.
636.
Muzzi DA, Black S, Cucchiara RF: The lack of
effect of succinylcholine on serum potassium in patients with Parkinson's disease.
Anesthesiology 71:322, 1989.
637.
Ngai SH: Parkinsonism, levodopa, and anesthesia.
Anesthesiology 37:344, 1972.
638.
Wiklund RA, Ngai SH: Rigidity and pulmonary edema
after Innovar in a patient on levodopa therapy: Report of a case. Anesthesiology
35:545–547, 1971.
639.
Skoog I, Nilsson J, Palmertz B, et al: A population-based
study of dementia in 85-year-olds. N Engl J Med 328:153, 1993.
640.
Petersen RC, Smith GE, Waring SC, et al: Mild
cognitive impairment: Clinical characterization and outcome. Arch Neurol 56:303–308,
1999.
641.
Ross GW, Abbott RD, Petrovitch H, et al: Frequency
and characteristics of silent dementia among elderly Japanese-American men. The
Honolulu-Asia Aging Study. JAMA 277:800, 1997.
642.
Snowdon DA, Greiner LH, Mortimer JA, et al: Brain
infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA
277:813, 1997.
643.
Drugs for Alzheimer's disease. Med Lett Drugs
Ther 43:53, 2001.
644.
Hemmelgarn B, Suissa S, Huang A, et al: Benzodiazepine
use and the risk of motor vehicle crash in the elderly. JAMA 278:27, 1997.
645.
Mozkowitz MA: Basic mechanisms in vascular headache.
Neurol Clin 8:801, 1990.
646.
Michel P, Henry P, Letenneur L, et al: Diagnostic
screen for assessment of IHS criteria for migraine by general practitioners. Cephalagia
12:54, 1993.
647.
MacIntyre PD, Bhargava B, Hogg KJ, et al: Effect
of subcutaneous sumatriptan, a selective 5HT-1 agonist, on the systemic, pulmonary,
and coronary circulation. Circulation 87:401, 1993.
648.
Shadick NA, Phillips CB, Logigian EL, et al:
The long-term clinical outcomes of Lyme disease. A population-based retrospective
cohort study. Ann Intern Med 121:560, 1994.
649.
Ovassapian A, Land P, Schafer MF, et al: Anesthetic
management for surgical corrections of severe flexion deformity of the cervical spine.
Anesthesiology 58:370, 1983.
650.
Dahm LS, Dickson JH, Harrison GH: Perioperative
and anesthetic management in the patient with scoliosis. Anesthesiol Rev 9:13, 1982.
651.
Ferguson RJ, Caplan LR: Cervical spondylitic
myelopathy. Neurol Clin 3:373, 1985.
652.
Rudick RA, Cohen JA, Weinstock-Guttman B, et al:
Management of multiple sclerosis. N Engl J Med 337:1604, 1997.
653.
Baskett PJF, Armstrong R: Anaesthetic problems
in multiple sclerosis: Are certain agents contraindicated? Anaesthesia 25:397,
1970.
654.
McKhann GM, Griffin JW, Cornblath DR, et al:
Plasmapheresis and Guillain-Barré syndrome: Analysis of prognostic factors
and the effect of plasmapheresis. Ann Neurol 23:347, 1988.
655.
Ancoli-Israel S, Klauber MR, Stepnowsky C, et
al: Sleep-disordered breathing in African-American elderly. Am J Respir Crit Care
Med 152:1946, 1995.
656.
Ostermeier AM, Roizen MF, Hautkappe M, et al:
Three sudden postoperative respiratory arrests associated with epidural opioids
in patients with sleep apnea. Anesth Analg 85:452, 1997.
657.
Aldrich MS: Narcolepsy. N Engl J Med 323:389,
1990.
658.
Cyr MG, Wartman SA: The effectiveness of routine
screening questions in the detection of alcoholism. JAMA 259:51, 1988.
659.
Toh B-H, van Driel IR, Gleeson PA: Pernicious
anemia. N Engl J Med 337:1441, 1997.
660.
Jensen NF, Fiddler DS, Striepe V: Anesthetic
considerations in porphyrias. Anesth Analg 80:591, 1995.
661.
Kantor G, Rolbin SH: Acute intermittent porphyria
and caesarean delivery. Can J Anaesth 39:282, 1992.
662.
Meissner PN, Harrison GG, Hift RJ: Propofol as
an I.V. anaesthetic induction agent in variegate porphyria. Br J Anaesth 66:60,
1991.
663.
McNeill MJ, Bennet A: Use of regional anaesthesia
in a patient with acute porphyria. Br J Anaesth 64:371, 1990.
664.
Massey JM: Treatment of acquired myasthenia gravis.
Neurology 48:S46–S51, 1997.
665.
d'Empaire G, Hoaglin DC, Perlo VP, et al: Effect
of prethymectomy plasma exchange on postoperative respiratory function in myasthenia
gravis. J Thorac Cardiovasc Surg 89:592, 1985.
666.
Eisenkraft JB, Book WJ, Mann SM, et al: Resistance
to succinylcholine in myasthenia gravis: A dose response study. Anesthesiology
69:760, 1988.
667.
Eisenkraft JB, Papatestas AE, Kahn CH, et al:
Predicting the need for postoperative mechanical ventilation in myasthenia gravis.
Anesthesiology 65:79, 1986.
668.
Small S, Ali HH, Lennon VA, et al: Anesthesia
for unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult
small cell lung carcinoma. Anesthesiology 76:142, 1992.
669.
Lema G, Urzua J, Moran S, Canessa R: Successful
anesthetic management of a patient with hypokalemic familial periodic paralysis undergoing
cardiac surgery. Anesthesiology 74:373, 1991.
670.
Ashwood EM, Russell WJ, Burrow DD: Hyperkalaemic
periodic paralysis. Anaesthesia 47:579, 1992.
671.
Gutmann DH, Fischbeck KH: Molecular biology of
Duchenne and Becker's muscular dystrophy: Clinical applications. Ann Neurol 26:189,
1989.
672.
Smith CL, Bush GH: Anesthesia and progressive
muscular dystrophy. Br J Anaesth 57:1113, 1985.
673.
Schwartz L, Rockoff MA, Koka BV: Masseter spasm
with anesthesia: Incidence and implications. Anesthesiology 61:772, 1984.
674.
Rosenberg H: Trismus is not trivial, editorial.
Anesthesiology 67:453, 1987.
675.
Pueschel SM, Scola FH: Atlantoaxial instability
in individuals with Down syndrome: Epidemiologic, radiographic, and clinical studies.
Pediatrics 80:55, 1987.
676.
Morray JP, MacGillivray R, Duker G: Increased
perioperative risk following repair of congenital heart disease in Down's syndrome.
Anesthesiology 65:221, 1986.
677.
Roizen NJ, Patterson D: Down's syndrome Lancet
361:1281–1289, 2003.
678.
Freeman SB, Taft LF, Dopoley KJ, et al: Population-based
study of congenital heart defects in Down syndrome. Am J Med Genet 80:213–217,
1998.
679.
Kobel M, Creighton RE, Steward DJ: Anaesthetic
considerations in Down's syndrome: Experience with 100 patients and a review of
the literature. Can J Anaesth 29:593, 1982.
680.
Bedford RF, Morris L, Jane JA: Intracranial hypertension
during surgery for supratentorial tumor: Correlation with preoperative computed
tomography scans. Anesth Analg 61:430, 1982.
681.
Ramirez-Lassepas M, Quinones MR: Heparin therapy
for stroke: Hemorrhagic complications and risk factors for intracerebral hemorrhage.
Neurology 34:114, 1984.
682.
Rem JA, Hachinski VC, Boughner DR, Barnett HJ:
Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke
16:950, 1985.
683.
Drugs for psychiatric disorders. Treatment guideline.
Med Lett Drugs Ther 11:69–76, 2003.
684.
Appel GB, Neu HC: The nephrotoxicity of antimicrobial
agents. N Engl J Med 296:663, 722, 784, 1977.
685.
Fischer RP, Polk HC Jr: Changing etiologic patterns
of renal insufficiency in surgical patients [editorial]. Surg Gynecol Obstet 140:85,
1975.
686.
Better OS, Stein JH: Early management of shock
and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med
322:825, 1990.
687.
Levey AS, Perrone RD, Madias NE: Serum creatinine
and renal function. Annu Rev Med 39:465, 1988.
688.
Byrick RJ, Rose DK: Pathophysiology and prevention
of acute renal failure: The role of the anaesthetist. Can J Anaesth 37:457, 1990.
689.
Berns AS: Nephrotoxicity of contrast media.
Kidney Int 36:730, 1989.
690.
Myers BD, Moran SM: Hemodynamically mediated
acute renal failure. N Engl J Med 314:97, 1986.
691.
Shusterman N, Strom BL, Murray TG, et al: Risk
factors and outcome of hospital-acquired acute renal failure: A clinical epidemiologic
study. Am J Med 83:65, 1987.
692.
Bernard DB: Extrarenal complications of the nephrotic
syndrome [clinical conference]. Kidney Int 33:1184, 1988.
693.
Thadhani R, Pascual M, Bonventre JV: Acute renal
failure. N Engl J Med 334:1448, 1996.
694.
Aronson S, Thisthelwaite RJ, Walker R, et al:
Safety and feasibility of renal blood flow determination during surgery with perfusion
ultrasonography. Anesth Analg 80:353, 1995.
695.
Hebert PC, Wells G, Blajchman MA, et al: A multicenter,
randomized, controlled clinical trial of transfusion requirements in critical care.
Transfusion Requirements in Critical Care Investigators, Canadian Critical Care
Trials Group. N Engl J Med 340:409–417, 1999.
696.
Rao KV, Anderson RC, O'Brien TJ: Factors contributing
for improved graft survival in recipients of kidney transplants. Kidney Int 24:210,
1983.
697.
Eschbach JW, Kelly MR, Haley NR, et al: Treatment
of the anemia of progressive renal failure with recombinant human erythropoietin.
N Engl J Med 321:158, 1989.
698.
Burke GR, Gulyassy PF: Surgery in the patient
with renal disease and related electrolyte disorders. Med Clin North Am 63:1191,
1979.
699.
Coe FL, Parks JH, Asplin JR: The pathogenesis
and treatment of kidney stones. N Engl J Med 327:1141, 1992.
700.
Kellen M, Aronson S, Roizen MF, et al: Predictive
and diagnostic tests of renal failure: A review. Anesth Analg 78:134, 1994.
701.
Shin B, Mackenzie CF, Helrich M: Creatinine clearance
for early detection of posttraumatic renal dysfunction. Anesthesiology 64:605, 1986.
702.
Novis BK, Roizen MF, Aronson S, Thisted RA: Association
of preoperative risk factors with postoperative acute renal failure. Anesth Analg
78:143, 1994.
703.
Rowe JW, Andres R, Tobin JD, et al: The effect
of age on creatinine clearance in men: A cross-sectional and longitudinal study.
J Gerontol 31:155, 1976.
704.
Lee TH, Marcantonio ER, Mangione CM, et al: Derivation
and prospective validation of a simple index for prediction of cardiac risk of major
noncardiac surgery. Circulation 100:1043–1049, 1999.
705.
Mangano CM, Diamondstone LS, Ramsay JG, et al:
Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes,
and hospital resource utilization. The Multicenter Study of Perioperative Ischemia
Research Group. Ann Intern Med 128:194–203, 1998.
706.
Koning HM, Koning AJ, Leusink JA: Serious acute
renal failure following open heart surgery. Thorac Cardiovasc Surg 33:283, 1985.
707.
Kleinknecht D, Ganeval D, Gonzalez-Duque LA, et
al: Furosemide in acute oliguric renal failure: A controlled trial. Nephron 17:51,
1976.
708.
Flancbaum L, Choban PS, Dasta JF: Quantitative
effects of low-dose dopamine on urine output in oliguric surgical intensive care
unit patients. Crit Care Med 22:61, 1994.
709.
Hanley MJ, Davidson K: Prior mannitol and furosemide
infusion in a model of ischemic acute renal failure. Am J Physiol 241:F556, 1981.
710.
Davis RF, Lappas DG, Kirklin JK, et al: Acute
oliguria after cardiopulmonary bypass: Renal functional improvement with low-dose
dopamine infusion. Crit Care Med 10:852, 1982.
711.
Polson RJ, Park GR, Lindop MJ, et al: The prevention
of renal impairment in patients undergoing orthotopic liver grafting by infusion
of low dose dopamine. Anaesthesia 42:15, 1987.
712.
Paul MD, Mazer CD, Byrick RJ, et al: Influence
of mannitol and dopamine on renal function during elective infrarenal aortic clamping
in man. Am J Nephrol 6:427, 1986.
713.
Crowley K, Clarkson K, Hannon V, et al: Diuretics
after transurethral prostatectomy: A double-blind controlled trial comparing furosemide
and mannitol. Br J Anaesth 65:337, 1990.
714.
Dorman, HR, Sondheimer JH, Cadnapaphornchai P:
Mannitol-induced acute renal failure. Medicine (Baltimore) 69:153–159, 1990.
715.
Kellum JA, Decker J: Use of dopamine in acute
renal failure: A meta-analysis. Crit Care Med 29:1526–1531, 2001.
716.
Alpert RA, Roizen MF, Hamilton WK, et al: Intraoperative
urinary output does not predict postoperative renal function in patients undergoing
abdominal aortic revascularization. Surgery 95:707, 1984.
717.
Murphy MB, McCoy CE, Wever RR, et al: Augmentation
of renal blood flow and sodium excretion in hypertensive patients during blood pressure
reduction by intravenous administration of the dopamine1 agonist fenoldopam. Circulation
76:1312–1318, 1987.
718.
Halpenny M, Lakshmi S, O'Donnell A, et al: The
effects of fenoldopam on coronary conduit blood flow after coronary artery bypass
graft surgery. J Cardiothorac Vasc Anesth 15:72–76, 2001.
719.
Halpenny M, Rushe C, Breen P, et al: The effects
of fenoldopam on renal function in patients undergoing elective aortic surgery.
Eur J Anaesthesiol 19:32–39, 2002.
720.
Caimmi PP, Pagani L, Micalizzi E, et al: Fenoldopam
for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac
Vasc Anesth 17:491–494, 2003.
721.
Litz RJ, Hubler M, Lorenz W, et al: Renal responses
to desflurane and isoflurane in patients with renal insufficiency. Anesthesiology
97:1133–1136, 2002.
722.
Conzen PF, Kharasch ED, Czerner SF, et al: Low-flow
sevoflurane compared with low-flow isoflurane anesthesia in patients with stable
renal insufficiency. Anesthesiology 97:578–584, 2002.
723.
Petroni KC, Cohen NH: Continuous renal replacement
therapy: Anesthetic implications. Anesth Analg 94:1288–1297, 2002.
724.
Dolan MJ, Whipp BJ, Davidson WD, et al: Hypopnea
associated with acetate hemodialysis: Carbon dioxide-flow-dependent ventilation.
N Engl J Med 305:72, 1981.
725.
Renal Data System: USRDS 2001 Annual Data Report:
Atlas of End Stage Renal Disease in the United States. Bethesda, MD, National Institute
of Diabetes and Digestive and Kidney Diseases, 2001.
726.
Roth S, Kuperberg JP: Adverse responses following
intraoperative administration of Orthoclone OKT3. Anesth Analg 62:822, 1989.
727.
Myers BD, Sibley R, Newton L, et al: The long-term
course of cyclosporine-associated chronic nephropathy. Kidney Int 33:590, 1988.
728.
Bennett WM, Aronoff GR, Morrison G, et al: Drug
prescribing in renal failure: Dosing guidelines for adults. Am J Kidney Dis 3:155,
1983.
729.
Rubin AL, Stenzel KH, Reidenberg MM: Symposium
on drug action and metabolism in renal failure. Am J Med 62:459, 1977.
730.
Bennett WM, Aronoff GR, Golper TA, et al: Drug
Prescribing in Renal Failure. Dosing Guidelines for Adults. 2nd ed. Philadelphia,
American College of Physicians, 1991.
731.
Gibson TP: Renal disease and drug metabolism:
An overview. Am J Kidney Dis 8:7, 1986.
732.
Goyal P, Puri GD, Pandey CK, Srivastva S: Evaluation
of induction doses of propofol: Comparison between endstage renal disease and normal
renal function patients. Anaesth Intensive Care 30:584–587, 2002.
733.
Dawling S, Crome P: Clinical pharmacokinetic
considerations in the elderly: An update. Clin Pharmacokinet 17:236, 1989.
734.
Keighley MRB: Antibiotics in biliary disease:
The relative importance of antibiotic concentrations in the bile and serum. Gut
17:495, 1976.
735.
Platt R, Zaleznik DF, Hopkins CC, et al: Perioperative
antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med 322:153,
1990.
736.
Chestnut DH: Spinal anesthesia in the febrile
patient. Anesthesiology 76:667, 1992.
737.
Rackow EC, Astiz ME: Pathophysiology and treatment
of septic shock. JAMA 266:548, 1991.
738.
Knaus WA, Wagner DP: Multiple systems organ failure:
Epidemiology and prognosis. Crit Care Clin 5:522, 1989.
739.
The choice of antibacterial drugs. Med Lett Drugs
Ther 46:13, 2004.
740.
Shapiro BA, Kacmarek RM, Cane RD, et al: Clinical
Application of Respiratory Care. 4th ed. St Louis, Mosby-Year Book, 1991.
741.
Shapiro ED, Berg AT, Austrian R, et al: The protective
efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 325:1453,
1991.
742.
Gardner P, Schaffner W: Immunization of adults.
N Engl J Med 328:1252, 1993.
743.
Brownstein AB, Roizen MF: A compelling rationale
for using preoperative visits to complete adult immunizations. J Clin Anesth 10:338,
1998.
744.
Schwartz D, Schwartz T, Cooper E, Pullerits J:
Anaesthesia and the child with HIV infection. Can J Anaesth 38:626, 1991.
745.
Platt R, Polk BF, Murdock B, et al: Mortality
associated with nosocomial urinary-tract infection. N Engl J Med 307:637, 1982.
746.
Albert RK, Condie F: Hand-washing patterns in
medical intensive-care units. N Engl J Med 304:1465, 1981.
747.
Farber BF, Kaiser DL, Wenzel RP: Relation between
surgical volume and incidence of postoperative wound infection. N Engl J Med 305:200,
1981.
